PT-141
Also known as: pt141, bremelanotide, vyleesi, melanocortin receptor agonist pt-141
Melanocortin receptor agonist (FDA-approved as Vyleesi) studied for sexual dysfunction in men and women.
Quick Reference
PT-141 - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Chemical compound
Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women. Specifically, it is used for low sexual desire which occurs before menopause and is not due to medical problems, psychiatric problems, or problems within the relationship. It is given by an injection just under the skin of the thigh or abdomen.
Mechanism of Action
Activates MC3R and MC4R in the central nervous system, inducing sexual arousal pathways independent of vascular effects.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
PT-141 (also known as pt141, bremelanotide) is studied within the sexual health and hormonal research community. Melanocortin receptor agonist (FDA-approved as Vyleesi) studied for sexual dysfunction in men and women.
Last updated October 28, 2026
Research status: active. PT-141 appears across sexual health and hormonal research forums and academic literature. Researchers note this compound falls in the sexual health category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with PT-141. Comments are reviewed before appearing.